Zacks Investment Research downgraded RadNet Inc. (NASDAQ:RDNT) to Hold in a report released today.
- Updated: October 15, 2016
Yesterday RadNet Inc. (NASDAQ:RDNT) traded -1.06% lower at $7.47. The company’s 50-day moving average is $7.15 and its 200-day moving average is $5.88. The last closing price is up 27.49% relative to the two hundred day average, compared with the Standard & Poor's 500 Index which has decreased -0.01% over the same period. Trade Volume was up over the average, with 129,362 shares of RDNT changing hands over the typical 111,375
Zacks Investment Research has downgraded RadNet Inc. (NASDAQ:RDNT) to Hold in a statement released on 10/12/2016.
Recent Performance Chart
RadNet Inc. has 52 week low of $4.66 and a 52 week high of $7.86 with a PE ratio of 32.57 and has a market capitalization of $0.
In addition to Zacks Investment Research reporting its stock price target, a total of 4 brokers have issued a report on the stock. The consensus target price is $9.25 with one brokerage rating the company a strong buy, two analysts rating the company a buy, one firm rating the stock a hold, 0 equity analysts rating the company a underperform, and lastly 0 brokers rating the stock a sell.
General Information About RadNet Inc. (NASDAQ:RDNT)
RadNet, Inc. is a provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. The Company operates directly or indirectly through joint ventures with hospitals, approximately 300 centers located in California, Delaware, Florida, Maryland, New Jersey, New York and Rhode Island. Its centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Its services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. It operates approximately 140 fixed-site, freestanding outpatient diagnostic imaging facilities in California, over 10 in Delaware, three in Florida, 50 in Maryland, 20 in New Jersey, 20 in the Rochester and Hudson Valley areas of New York, approximately 40 in New York City, as well as five in Rhode Island.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.